AstraZeneca has pulled its Covid vaccine from the worldwide market for “purely commercial” reasons because improved products are now available, according to major media reports. The backstory is that the company has been sued and admitted in court of dangerous blood clotting issues in patients.
Retired Air Force Major Tom Haviland meets with The New American senior editor Rebecca Terrell to discuss these latest developments. He has been researching Covid-jab-related adverse effects since losing his job in 2021 as a military contractor. His crime: refusing Biden’s mandates.
Haviland’s research indicates that blood clotting issues from other Covid vaccine manufacturers are just as bad as those caused by AstraZeneca. Embalmers in the United States have reported rampant “white fibrous clots” in cadavers since the Covid pandemic. Haviland also has new information from cardiologist and endovascular specialist reports that the same phenomenon is turning up in living patients.
